Vaccination against seasonal flu offers Waldenstrom's macroglobulinaemia (WM) patients, who often have weakened immune systems, some protection against the most common strains of flu. The flu vaccine is therefore recommended in all and preferably also family members of WM patients to keep the flu levels low in the community.
WMUK has joined forces with 19 other less common cancer charities to create a unique and exciting 20-day challenge. The 20for20 Challenge aim is to raise funds to make up the shortfall in our income due to the COVID-19 pandemic. Funds that are vital to enable us to continue with our work. Find out more here.
Our latest factsheet written by Dr Dima El-Sharkawi, WMUK trustee and Consultant Haematologist at the Royal Marsden Hospital, London, looks to answer some of the questions currently being asked of doctors and nurses in clinic consultations, regarding how much people with WM should still be avoiding others.
We are very keen to hear from any WM patients who are currently taking zanubrutinib in the UK. If you would be prepared to share your experiences to inform our work on a forthcoming NICE appraisal, please do get in touch.
Congratulations from everyone at WMUK to the incredible R4AR JOGLE 2020 cyclists on completing their John O’Groats to Land’s End challenge, having cycled through Storm Ellen and Storm Frances to raise nearly £40,000 for their chosen charities - WMUK, The Brain Tumour Charity and Headcase Cancer Trust, in memory of Rory Morrison and Alex Baigler.
We urgently need patients with Waldenstrom's macroglobulinaemia to join our Rory Morrison WMUK Registry - Quality of Life Project, collecting data around experiences of living with WM and helping us to better understand the WM landscape in the UK.
A recording of our joint webinar "WM and COVID-19" held in partnership with Lymphoma Action on Friday 19th June, is now available for those who were not able to join us on the day, or who wish to watch it again.
Advice for Waldenstrom's macroglobulinaemia (WM) patients from Dr Shirley D’Sa, WMUK trustee and lead WM clinician at UCLH, in response to the Government's plans to ease shielding for people who are shielding in England, from Monday 6 July.
Dr Shirley D'Sa, WMUK Trustee and Consultant Haematologist and WM lead at University College London Hospitals, explains the science behind the current COVID-19 pandemic and what we know about this virus.
The COVID Symptom Tracker developed by ZOE Global Limited, alongside King's College London, to study the symptoms and spread of COVID-19, have now partnered with the UK's leading charities and all of the Royal Medical Colleges, to better understand the virus in those who are more vulnerable. To help support this important initiative, more volunteers are needed to take part.